INRLFOTCHealthcare · Biotechnology

Valneva SE

$2.58+0.00%(+$0.00)

TickerSpark Score

44/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INRLF research report →

52-Week Range3% of range

Low $2.46

Current $2.58

High $6.28

Companyvalneva.com

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus.

CEO: Thomas Lingelbach
IPO: 2010
Employees: 713
HQ: Saint-Herblain, FR

Price Chart

-20.62% · this period

Valuation

Market Cap: $489.29M
P/E: -3.10
P/S: 3.02
P/B: 5.59
EV/EBITDA: -6.66
Div Yield: 0.00%

Profitability

Gross Margin: 29.46%
Op Margin: -68.81%
Net Margin: -88.30%
ROE: -106.22%
ROIC: -36.00%

Growth & Income

Revenue: $174.66M · 3.00%
Net Income: $-115,192,000 · -840.57%
EPS: $-0.68 · -630.40%
Op Income: $-81,631,000
FCF YoY: 31.42%

Performance & Tape

52W High: $6.28
52W Low: $2.46
50D MA: $3.30
200D MA: $4.37
Beta: 1.95
Avg Volume: 374

Get TickerSpark's AI analysis on INRLF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime